What it is
HRV is the beat-to-beat variation in your heart rhythm — a marker of autonomic nervous system balance. Recovery-focused wearables report it nightly.
Why it matters for longevity
Across 32 studies covering over 38,000 people, lower HRV predicted higher mortality. The headline HR 1.56 is the UNADJUSTED comparison of the lowest quartile of 5-minute ECG RMSSD versus the other three quartiles — not wearable nightly HRV. As of 2026-08-29 this calculator's curve uses the paper's smaller covariate-adjusted estimate (~1.23) instead. The measurement mismatch remains: users enter overnight wearable RMSSD. Saito 2025 (fingertip PPG, 5-min sitting rest) and Schaarup 2025 (ActiHeart chest ECG, multi-day SDNN) are nearby but not that construct — no all-cause HR for overnight consumer-wrist RMSSD has been found.
How to improve it
- Improve sleep quantity and regularity
- Train aerobically but respect recovery
- Practice slow breathing; limit late alcohol
Evidence, by endpoint
| Endpoint | Grade | Finding |
|---|---|---|
| All-cause mortality (RMSSD lowest quartile) | C | Bottom Quartile (Jarczok 2022) Unadjusted, the lowest quartile of 5-minute ECG RMSSD had HR 1.56 vs the other three quartiles. This calculator uses the paper’s smaller covariate-adjusted estimate (~1.23). |
| All-cause mortality (overnight wrist RMSSD) | X | Not overnight wrist RMSSD Jarczok is 5-minute ECG. Saito 2025 is 5-minute fingertip PPG; Schaarup 2025 is chest-ECG multi-day SDNN. No all-cause HR for overnight consumer-wrist RMSSD has been found. |
| All-cause mortality (per 1-SD lower LF power) | B | 1.70x per SD of LF Power (Tsuji 1994) Framingham: in 736 elderly adults (mean age 72) followed 4 years, each 1-SD lower low-frequency HRV power carried ACM HR 1.70 (1.37–2.09), independent of traditional risk factors — a different metric again (LF power), and different from the overnight wearable RMSSD users actually enter. |
| Cardiac mortality (SDNN quartile, U-shaped) | C | U-Shaped, Not Just Low HRV (de Bruyne 1999) Rotterdam Study measured heart-rate variability (SDNN) via a standard 10-second ECG in over 5,000 adults 55+: the lowest SDNN quartile carried 80% higher cardiac mortality than the middle quartile (HR 1.8, 95% CI 1.0–3.2) — but so, unexpectedly, did the highest quartile (HR 2.3, 95% CI 1.3–4.0), a U-shaped pattern the authors said needed further study. |
What argues against this
No source in this set reverses the direction of the low-HRV-worse association outright, but de Bruyne 1999 (Rotterdam Study, >5,000 adults 55+) complicates the engine's implicit monotonic framing: the lowest SDNN quartile carried 80% higher cardiac mortality (HR 1.8, 1.0–3.2) versus the middle quartile, but so did the highest quartile (HR 2.3, 1.3–4.0) — a U-shaped pattern suggesting very high HRV is not straightforwardly protective either. It measures cardiac mortality via 10-second ECG SDNN, not the all-cause mortality / 5-minute RMSSD construct Jarczok 2022 and this calculator use, so it disagrees on shape and construct, not sign.
Last reviewed 2 September 2026
Evidence
- Jarczok et al. (2022) — Neuroscience & Biobehavioral ReviewsHeart rate variability in the prediction of mortality: a systematic review and meta-analysisView source
- Dekker et al. (2000) — CirculationLow heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC Study. Atherosclerosis Risk In CommunitiesView source
- Saito et al. (2025) — Circulation ReportsPulse Rate Variability and All-Cause Mortality Risk in the General Japanese PopulationView source
- de Bruyne et al. (1999) — American Journal of EpidemiologyBoth decreased and increased heart rate variability on the standard 10-second electrocardiogram predict cardiac mortality in the elderly: the Rotterdam StudyView source
- Tsuji et al. (1994) — CirculationReduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart StudyView source
- Schaarup et al. (2025) — Diabetes, Obesity and MetabolismCardiovascular autonomic dysfunction precedes cardiovascular disease and all-cause mortality: 11-year follow-up in the ADDITION-PRO studyView source
Educational content only — not medical advice, diagnosis, or treatment. Not a medical device; not FDA evaluated. Consult a qualified healthcare professional about your own health, and call emergency services for urgent symptoms. Full medical disclaimer →